IRIS Accounts Production v26.1.10.61 15587704 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh155877042025-03-31155877042026-03-31155877042025-04-012026-03-31155877042024-03-22155877042024-03-232025-03-31155877042025-03-3115587704ns15:EnglandWales2025-04-012026-03-3115587704ns14:PoundSterling2025-04-012026-03-3115587704ns10:Director12025-04-012026-03-3115587704ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3115587704ns10:SmallEntities2025-04-012026-03-3115587704ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3115587704ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3115587704ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3115587704ns10:FullAccounts2025-04-012026-03-3115587704ns10:OrdinaryShareClass12025-04-012026-03-3115587704ns10:Director22025-04-012026-03-3115587704ns10:RegisteredOffice2025-04-012026-03-3115587704ns5:CurrentFinancialInstruments2026-03-3115587704ns5:CurrentFinancialInstruments2025-03-3115587704ns5:ShareCapital2026-03-3115587704ns5:ShareCapital2025-03-3115587704ns5:RevaluationReserve2026-03-3115587704ns5:RevaluationReserve2025-03-3115587704ns5:FurtherSpecificReserve1ComponentTotalEquity2026-03-3115587704ns5:FurtherSpecificReserve1ComponentTotalEquity2025-03-3115587704ns5:RetainedEarningsAccumulatedLosses2026-03-3115587704ns5:RetainedEarningsAccumulatedLosses2025-03-3115587704ns5:FurnitureFittings2025-04-012026-03-3115587704ns5:ComputerEquipment2025-04-012026-03-3115587704ns5:FurnitureFittings2026-03-3115587704ns5:ComputerEquipment2026-03-3115587704ns5:CostValuation2025-03-3115587704ns5:AdditionsToInvestments2026-03-3115587704ns5:DisposalsRepaymentsInvestments2026-03-3115587704ns5:RevaluationsIncreaseDecreaseInInvestments2026-03-3115587704ns5:CostValuation2026-03-3115587704ns5:DeferredTaxation2026-03-3115587704ns10:OrdinaryShareClass12026-03-3115587704ns5:RetainedEarningsAccumulatedLosses2025-03-3115587704ns5:RevaluationReserve2025-03-3115587704ns5:FurtherSpecificReserve1ComponentTotalEquity2025-03-3115587704ns5:RetainedEarningsAccumulatedLosses2025-04-012026-03-31
REGISTERED NUMBER: 15587704 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 March 2026

for

Morpho Holdings Limited

Morpho Holdings Limited (Registered number: 15587704)






Contents of the Financial Statements
for the Year Ended 31 March 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Morpho Holdings Limited

Company Information
for the Year Ended 31 March 2026







DIRECTORS: Professor V C Lees
Dr A Pawade





REGISTERED OFFICE: Brunel House
11 The Promenade
Clifton
Bristol
BS8 3NG





REGISTERED NUMBER: 15587704 (England and Wales)





ACCOUNTANTS: Wormald & Partners
Chartered Accountants (ICAEW)
Brunel House
11 The Promenade
Clifton Down
Bristol
BS8 3NG

Morpho Holdings Limited (Registered number: 15587704)

Balance Sheet
31 March 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,853 -
Investments 5 1,197,575 247,063
Investment property 6 313,000 -
1,513,428 247,063

CURRENT ASSETS
Debtors 7 121,576 -
Cash at bank 192,301 1,031
313,877 1,031
CREDITORS
Amounts falling due within one year 8 4,750 257,254
NET CURRENT ASSETS/(LIABILITIES) 309,127 (256,223 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,822,555

(9,160

)

PROVISIONS FOR LIABILITIES 9 110,130 -
NET ASSETS/(LIABILITIES) 1,712,425 (9,160 )

CAPITAL AND RESERVES
Called up share capital 10 200 200
Revaluation reserve 11 56,863 -
Non Distributable Reserves on
Fair Value Gains 11 411,272 -
Retained earnings 11 1,244,090 (9,360 )
SHAREHOLDERS' FUNDS 1,712,425 (9,160 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 October 2026 and were signed on its behalf by:




Professor V C Lees - Director


Morpho Holdings Limited (Registered number: 15587704)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1. STATUTORY INFORMATION

Morpho Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
Additions 1,423 2,677 4,100
At 31 March 2026 1,423 2,677 4,100
DEPRECIATION
Charge for year 356 891 1,247
At 31 March 2026 356 891 1,247
NET BOOK VALUE
At 31 March 2026 1,067 1,786 2,853

Morpho Holdings Limited (Registered number: 15587704)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

5. FIXED ASSET INVESTMENTS
Shares in
group Other
undertakings investments Totals
£    £    £   
COST OR VALUATION
At 1 April 2025 100 246,963 247,063
Additions - 524,035 524,035
Disposals - (81,266 ) (81,266 )
Revaluations - 507,743 507,743
At 31 March 2026 100 1,197,475 1,197,575
NET BOOK VALUE
At 31 March 2026 100 1,197,475 1,197,575
At 31 March 2025 100 246,963 247,063

Cost or valuation at 31 March 2026 is represented by:

Shares in
group Other
undertakings investments Totals
£    £    £   
Valuation in 2026 - 507,743 507,743
Cost 100 689,732 689,832
100 1,197,475 1,197,575

If fixed asset investments had not been revalued they would have been included at the following historical cost:

2026 2025
£    £   
Cost 689,732 -

Fixed asset investments were valued on an open market basis basis on 31 March 2026 by the portfolio managers. .

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
Additions 242,798
Revaluations 70,202
At 31 March 2026 313,000
NET BOOK VALUE
At 31 March 2026 313,000

Fair value at 31 March 2026 is represented by:
£   
Valuation in 2026 70,202
Cost 242,798
313,000

Morpho Holdings Limited (Registered number: 15587704)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

6. INVESTMENT PROPERTY - continued

If investment property had not been revalued it would have been included at the following historical cost:

2026 2025
£    £   
Cost 242,798 -

Investment property was valued on an open market basis on 31 March 2026 by the Directors. .

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Amounts owed by group undertakings 121,576 -

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Amounts owed to group undertakings - 256,467
Deposit held 1,450 -
Directors' loan accounts 105 105
Rent in advance 795 -
Accrued expenses 2,400 682
4,750 257,254

9. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax 110,130 -

Deferred
tax
£   
Provided on fair value uplift 109,810
Timing differences 320
Balance at 31 March 2026 110,130

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
200 Ordinary £1 200 200

Morpho Holdings Limited (Registered number: 15587704)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

11. RESERVES
Non
Distributable
Reserves
on Fair
Retained Revaluation Value
earnings reserve Gains Totals
£    £    £    £   

At 1 April 2025 (9,360 ) - - (9,360 )
Profit for the year 1,721,585 1,721,585
Transfer of Revaluation
Reserve (56,863 ) 56,863 - -
Transfer of Fair Value Gains (411,272 ) - 411,272 -
At 31 March 2026 1,244,090 56,863 411,272 1,712,225

12. RELATED PARTY DISCLOSURES

Morpho Holdings Ltd is the parent company of one wholly owned subsidiary, Vivien Lees Ltd (Company number: 07836524). Vivien Lees Ltd ceased trading on 31 July 2025.

At the start of the year, Morpho Holdings Ltd owed Vivien Lees Ltd £256,467, and this amount was included within creditors.

Vivien Lees Ltd voted dividends of £1,244,957 to Morpho Holdiongs Ltd during the year, of which £866,914 were paid before the year end.

At the year end, Vivien Lees Ltd owed Morpho Holdings Ltd £121,576, and this amount is included within debtors.